Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin–piperaquine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial
In: The Lancet, Jg. 386 (2015-12-19), Heft 10012, S. 2507-2519
Online
serialPeriodical
Zugriff:
Every year, more than 32 million pregnancies in sub-Saharan Africa are at risk of malaria infection and its adverse consequences. The effectiveness of the intermittent preventive treatment with sulfadoxine–pyrimethamine strategy recommended by WHO is threatened by high levels of parasite resistance. We aimed to assess the efficacy and safety of two alternative strategies: intermittent screening with malaria rapid diagnostic tests and treatment of women who test positive with dihydroartemisinin–piperaquine, and intermittent preventive treatment with dihydroartemisinin–piperaquine.
Titel: |
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin–piperaquine versus intermittent preventive treatment with sulfadoxine–pyrimethamine for the control of malaria during pregnancy in western Kenya: an open-label, three-group, randomised controlled superiority trial
|
---|---|
Autor/in / Beteiligte Person: | Desai, Meghna ; Gutman, Julie ; L'lanziva, Anne ; Otieno, Kephas ; Juma, Elizabeth ; Kariuki, Simon ; Ouma, Peter ; Were, Vincent ; Laserson, Kayla ; Katana, Abraham ; Williamson, John ; ter Kuile, Feiko O |
Link: | |
Zeitschrift: | The Lancet, Jg. 386 (2015-12-19), Heft 10012, S. 2507-2519 |
Veröffentlichung: | 2015 |
Medientyp: | serialPeriodical |
ISSN: | 0140-6736 (print) ; 1474-547X (print) |
DOI: | 10.1016/S0140-6736(15)00310-4 |
Sonstiges: |
|